Clot formation and clot stability in severe haemophilia A - effect of recombinant factor VIII and tranexamic acid.
Phase 1
- Conditions
- Severe haemophilia A
- Registration Number
- EUCTR2005-005103-41-DK
- Lead Sponsor
- Anne Mette Hvas
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- Male
- Target Recruitment
- Not specified
Inclusion Criteria
Patients above 18 years old
Severe haemophilia A
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Patients with inhibitory antibodies against factor VIII
Renal insufficiency
HIV-positive patients
Allergy against tranexamic acid
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method